The nurse noticed an increase in the prevalence of pressure injury among clients in the intensive care unit (ICU). The nurse documented the findings and worked with the manager to develop and implement a new policy addressing the consistent use of pressure injury risk assessment scale. Which term best describes the nurse's actions?

A. The medication will open the airways: Albuterol is a bronchodilator that works by relaxing the muscles around the airways, leading to dilation and increased airflow. This action helps to relieve symptoms of asthma or chronic obstructive pulmonary disease (COPD), making it easier for the client to breathe. The nurse should emphasize that opening the airways is a primary function of albuterol, providing immediate relief during breathing difficulties.
B. The medication will stimulate the flow of mucus: Albuterol does not primarily stimulate mucus production; rather, its main role is to relax bronchial smooth muscle and open the airways. While effective airway management may lead to improved mucus clearance due to enhanced airflow, albuterol itself does not directly promote mucus secretion. Thus, this statement does not accurately describe the action of the medication.
C. The medication will decrease coughing episodes: By opening the airways and improving airflow, albuterol can help reduce coughing episodes associated with bronchospasm or airway constriction. When the airways are less constricted, the client is less likely to experience the irritative cough often seen in respiratory conditions like asthma. This is an important point for the nurse to convey to help the client understand the medication's benefits.
D. The medication will prevent wheezing: Albuterol can help prevent or relieve wheezing by relaxing the bronchial muscles and facilitating better airflow. Wheezing often occurs when the airways are narrowed or constricted, and by using albuterol, the client can experience fewer wheezing episodes during respiratory distress. The nurse should explain this aspect to reinforce the medication's role in managing asthma or COPD symptoms.
E. The medication will reduce inflammation: Albuterol is not an anti-inflammatory medication; it primarily functions as a bronchodilator. While it can improve breathing by relaxing airway muscles, it does not directly target inflammation in the airways. Inhaled corticosteroids or other anti-inflammatory medications are typically used to address inflammation. Therefore, this response does not accurately reflect the action of albuterol.

A. Develop a quality improvement program for nurses involved in medication administration errors. While quality improvement programs are essential, implementing a targeted program without first analyzing the root causes of errors may not effectively address the underlying issues. A broader review of system-wide factors contributing to medication errors is necessary before designing an intervention.
B. Require staff nurses to demonstrate competency by passing a medication administration examination. Competency assessments may help identify knowledge gaps, but they do not address system-based errors such as workload issues, unclear protocols, or distractions during medication administration. A root cause analysis should be conducted first to ensure that interventions target the actual sources of errors.
C. Provide an inservice on medication administration to all the nurses. Educational sessions can reinforce safe practices, but without identifying the specific factors contributing to errors, they may not be effective. Training should be tailored to address the findings from an initial review of the medication errors.
D. Review the events leading up to each medication administration error. The first step in continuous quality improvement is conducting a thorough analysis of the errors, identifying patterns, and determining root causes. This helps in designing targeted interventions, whether they involve process changes, additional training, or improved safety protocols.